I. Toura

Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors.

M. Taniguchi, H. Koseki, T. Shin, 1997, Science.

Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide.

M. Taniguchi, T. Nakayama, T. Ochiai, 1999, Journal of immunology.

Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells.

Y. Tanaka, M. Taniguchi, H. Koseki, 1998, Proceedings of the National Academy of Sciences of the United States of America.

A CASE OF PRIMARY ADRENAL NON-HODGKIN'S B-CELL LYMPHOMA WHICH FORMED BILATERAL LARGE MASSES

H. Matsubara, I. Toura, M. Ichinose, 2008 .

Galactosylceramide α with Tumor Metastasis by Dendritic Cells Pulsed Cutting Edge : Inhibition of Experimental

Y. Akutsu, T. Kawano, I. Toura, 1999 .

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides.

Hiroshi Sato, M. Taniguchi, H. Koseki, 1997, Science.

Requirement for Vα14 NKT Cells in IL-12-Mediated Rejection of Tumors

Hiroshi Sato, M. Taniguchi, H. Koseki, 1997 .